foxo4 dri peptide senolytic study

foxo4 dri peptide senolytic study 2024 FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: The Senolytic That – FOXO4-DRI - Beverly Hills Rejuvenation

Name: foxo4 dri peptide senolytic study 2024 FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: The Senolytic That – FOXO4-DRI - Beverly Hills Rejuvenation
Brand: lagence-mr.com
SKU: 92029263746
Price: 23.92 USD
Availability: InStock
Rating: 4.1359 (19 reviews)

FOXO4 DRI Beverly Hills Rejuvenation Center The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 92029263746 · From lagence-mr.com

4.1

USD23.92 USD61.92

Pay in 4 interest-free payments of $5.98 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

Description

Side-by-Side Reference Attribute Class SLU-PP-332 Synthetic small-molecule pan-ERR agonist MOTS-c Mitochondrial-derived peptide (16 aa) AOD-9604 Modified GH fragment (aa 176-191) Attribute Primary target SLU-PP-332 ERR / / nuclear receptors MOTS-c AMPK activation and mitochondrial signaling AOD-9604 Lipolysis pathways without GH-receptor signaling Attribute Half-life SLU-PP-332 Not formally published